Market Place
Sourcing Support
Tris Pharma`s Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024
03 Sep 2024 //
BUSINESSWIRE
Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol
22 Aug 2024 //
BUSINESSWIRE
Tris Pharma Presents Data On Cebranopadol For Pain Treatment
06 Aug 2024 //
BUSINESSWIRE
Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress
30 Jul 2024 //
BUSINESSWIRE
Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Cebranopadol
05 Sep 2023 //
BUSINESSWIRE
Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH`S Cebranopadol
28 Aug 2023 //
BUSINESSWIRE
Tris Pharma Reports Positive Topline Data from Clinical Study of Cebranopadol
13 Dec 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.